GET
TO KNOW
OUR TEAM

Amit is a 30+ year industry veteran who is passionate about developing transformative medicines. Amit was most recently President and CEO of Arena Pharmaceuticals Inc. (Nasdaq:ARNA) where he built the company from a $300M market cap into a late clinical stage company with 37 programs, 4 drugs, and 11 indications before their $6.7B acquisition by Pfizer.

Peter has over 30+ years of industry experience and is a proven leader in early drug discovery and development having held key senior roles at Alnylam Pharmaceuticals, Moderna Therapeutics, and Millennium Pharmaceuticals where he has led the development of numerous NDAs and BLAs including several in the RNA space. He has a unique set of experience building and leading teams across multiple RNA modalities and delivery platforms.

Brian has 20+ years of experience in healthcare corporate development including leadership positions at JPMorgan where he was involved in 15 M&A transactions and 30 financings for biotech and pharmaceutical clients. Additionally, he held leadership positions at Johnson & Johnson where he executed 25 strategic transactions.

Ciaran has deep experience in building and leading teams across biotech and consulting sectors. He recently held principal leadership role at The Boston Consulting Group where he led large projects / programs across corporate strategy, R&D operations, M&A, and commercial. Ciaran was previously an early scientific lead at Moderna where he helped build out delivery capabilities.

Laurie has over 25 years of experience supporting the finance functions for biopharma companies, most recently as CFO of Mirati Therapeutics. Previously, she served as CFO of Arena Pharmaceuticals, where she helped lead the growth of the company toward its $6.7B acquisition by Pfizer. She was also CFO at Halozyme Therapeutics, where she led the company’s finance, IT, business development, and project management functions. She also held senior management roles at Shire, including Senior Vice President of Finance, Division CFO for the Regenerative Medicine Division, and Head of Investor Relations. She began her biotech career at Amgen, where she spent 15 years in positions of increasing responsibility, holding multiple roles in finance, global commercial operations, treasury and international/emerging markets. Laurie received her B.S. in Accounting from Arizona State University and her M.B.A. from the Anderson School of Management at the University of California, Los Angeles.

Lucas has extensive expertise across all aspects of human resources in the life sciences and biopharmaceutical industries. He most recently served as Chief Human Resources Officer at PhenomeX (previously known as Berkeley Lights, until its acquisition of IsoPlexis in December 2022), developing its human capital and talent function to support growth opportunities. Previously, he served as Senior Vice President of Human Resources at Arena Pharmaceuticals, until its acquisition by Pfizer in 2022. Prior roles also include Chief Human Resources Officer at NuVasive, and multiple Human Resources leadership positions at Life Technologies. Mr. Vitale earned Bachelor of Science degrees in Business Administration from Hawaii Pacific University, and a master’s degree in Industrial and Organizational Psychology from Alliant International University.